Screener Summaries Updates Institutions Sign In More Updates › Earnings › KMDA Earnings · Nov 2, 2026
Kamada to report Q3 and nine-month financial results on November 9 KMDA Kamada Ltd
Kamada Ltd. will release its third quarter and nine months ended September 30, 2026, financial results prior to the open of U.S. markets on Monday, November 9, 2026. Management will host a conference call at 8:30 am ET to discuss the results. Kamada Ltd. is a global biopharmaceutical company specializing in specialty plasma-derived therapies and products for rare conditions.
More from Kamada Ltd Kamada launches Ustekinumab and Enoxaparin biosimilars in Israel, targeting $4M sales in 2026 Oct 6, 2026 Kamada Ltd. announced it obtained a tax ruling from the Israel Tax Authority regarding its previously declared cash… Sep 3, 2026 Kamada Ltd. declared a cash dividend of $0.17 per share, totaling approximately $9.8 million, consistent with its… Aug 17, 2026 Kamada Ltd. reported record-high first-half 2026 revenues of $100.2 million, a 13% year-over-year increase, with… Aug 12, 2026 Kamada Ltd. announced it will release financial results for the second quarter and first half ended June 30, 2026… Aug 5, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
